Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Niimi

Showing results (201-210 of 207) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 207 results.
The Journal of Antimicrobial Chemotherapy|March 18, 2010
Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosityK Niimi, B C Monk, A Hirai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivoM Niimi, T C Pearson, C P Larsen, et al.
Japanese Journal of Clinical Oncology|May 8, 2000
Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology GroupT Takenaka, C Mikuni, A Miura, et al.
Japanese Journal of Clinical Oncology|January 25, 2000
Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology GroupT Takenaka, S Shirakawa, C Mikuni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505K Itoh, T Ohtsu, H Fukuda, et al.
Journal of Gastroenterology|May 6, 2015
Proton pump inhibitor after endoscopic resection for esophageal squamous cell cancer: multicenter prospective randomized controlled trialN Kakushima, K Hori, H Ono, et al.
Japanese Journal of Clinical Oncology|September 2, 1999
Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study GroupT Kobayashi, K Tobinai, M Shimoyama, et al.
Pageof 21

Showing results (201-210 of 207) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
The Journal of Antimicrobial Chemotherapy|March 18, 2010
Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosityK Niimi, B C Monk, A Hirai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivoM Niimi, T C Pearson, C P Larsen, et al.
Japanese Journal of Clinical Oncology|May 8, 2000
Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905). The Lymphoma Study Group of the Japan Clinical Oncology GroupT Takenaka, C Mikuni, A Miura, et al.
Japanese Journal of Clinical Oncology|January 25, 2000
Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology GroupT Takenaka, S Shirakawa, C Mikuni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505K Itoh, T Ohtsu, H Fukuda, et al.
Journal of Gastroenterology|May 6, 2015
Proton pump inhibitor after endoscopic resection for esophageal squamous cell cancer: multicenter prospective randomized controlled trialN Kakushima, K Hori, H Ono, et al.
Japanese Journal of Clinical Oncology|September 2, 1999
Long-term follow-up results of adult patients with acute lymphocytic leukemia or lymphoblastic lymphoma treated with short-term, alternating non-cross-resistant chemotherapy: Japan Clinical Oncology Group Study 8702. Lymphoma Study GroupT Kobayashi, K Tobinai, M Shimoyama, et al.
Pageof 21